Sinopharm Tech Holdings Limited

Sinopharm Tech Holdings Limited

HHKEX:8156
0.18
HKD
-0.01
(-6.38%)
-0.15EPS
24.25MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
1
0.35
0.78
0.96
0.27
0.2
0.19
0.31
1.01
0.45
0.23
0.23
0.22
0.25
Basic EPS, GAAP
-10.6
-0.37
0.12
0.15
-1.61
-1.35
-0.46
-0.34
-0.98
-0.62
-0.49
-0.06
-0.11
-0.16
Free Cash Flow per Basic Share
-0.15
-0.53
-0.04
-0.14
-0.38
-0.49
-0.23
-0.24
- -
-0.09
-0.21
0.03
-0.07
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.38
0.33
2.54
2.69
1.06
- -
-0.45
0.23
-0.43
-0.79
-0.92
-0.94
-1.09
-0.96
Tangible Book Value per Share
-0.52
-0.49
1.41
1.18
0.17
-0.55
-1.55
-0.9
-0.7
-0.86
-0.92
-0.94
-1.09
-0.98
Basic Weighted Avg Shares
104
113
123
128
129
130
132
138
165
172
180
183
184
184
Sales/Revenue/Turnover
105
39
96
124
35
26
25
44
166
78
41
43
41
47
Operating Margin (%)
-31.72
-92.11
22.59
19.16
-367.67
-458.69
-294.98
-78.91
-12.93
-50.8
-73.43
-36.43
-28.47
-24.27
Depreciation Expense
16
5
6
4
8
9
13
11
9
10
2
2
1
- -
Net Income, GAAP
-1,108
-42
15
19
-207
-175
-61
-47
-161
-106
-88
-11
-20
-29
Effective Tax Rate (%)
- -
- -
31.47
11.55
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1,056.4
-106.45
15.54
15.44
-596.64
-664.01
-240.79
-107.57
-97.07
-136.66
-214.71
-24.83
-47.72
-61.98
Working Capital
-1
-26
233
213
4
-74
-205
-148
-192
-223
-202
-186
-211
-192
LT Debt
74
76
64
73
- -
- -
- -
- -
8
4
- -
- -
1
- -
Total Equity
47
45
337
358
149
11
-60
37
-73
-141
-173
-180
-206
-183
Return on Invested Capital (%)
- -
- -
7.43
6.65
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
8.08
7.17
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-188.29
-104.18
8.11
5.68
-85.83
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

HKD

•

in mil. unless spec.
Jun'23
Sep'24
Dec'24
ST Debt
53
- -
10
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
184
184
184
Market Capitalization
64
25
24

Working Capital

HKD

•

in mil. unless spec.
Jun'23
Sep'24
Dec'24
Total Current Assets
27
- -
37
Cash, Cash Equivalents & STI
2
- -
9
Accounts Receivable, Net
8
- -
94
Inventories
1
- -
6
Total Current Liabilities
213
- -
229
Payables & Accruals
- -
- -
- -
ST Debt
53
- -
10
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-113.77%
-32.82%
14.38%
Free Cash Flow
-322.87%
-735.13%
-365.81%
Net Income, GAAP
-106.74%
38.06%
85.22%
Sales/Revenue/Turnover
18.29%
36.37%
-3.65%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
43
2024
- -
- -
41
2025
- -
- -
- -

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.06
2024
- -
- -
-0.11
2025
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Shuk Yi Kwok
Full Time Employees
31
Sector
Consumer services
Industry
Movies/Entertainment
Address
Ruttonjee House Hong Kong Hong Kong
IPO Date
Nov 12, 2002
Business
Sinopharm Tech Holdings Limited Sinopharm Tech Holdings Limited (8156.HK) is an investment holding company engaged in internet plus solution services, supply chain management and pharmaceutical distribution primarily in China and Hong Kong. The company provides lottery-related hardware and software systems; internet plus solution services including supply chain management, data analysis, logistics, drug traceability leveraging AI and big data; distribution of Chinese patent medicines and health products through a PRC subsidiary; and one-stop product supply chain services via platform operators in Mainland China. It serves sectors such as healthcare, government affairs, public security and big health industries with target customers including healthcare providers, product suppliers and platform operators. Founded in 1999 and headquartered in Central, Hong Kong, the company, formerly known as China Vanguard You Champion Holdings Limited, changed its name in June 2019 and listed on the GEM board of The Stock Exchange of Hong Kong Limited in November 2002. In recent developments, the group established a PRC subsidiary to expand distribution of Chinese patent medicines and health products, providing new revenue streams; continued stable growth in Internet Plus supply chain services while discussing value-added service cooperations with industry operators and suppliers; and exited the personal protective equipment manufacturing and distribution business to reallocate resources toward healthcare supply chain investments following reduced pandemic-related demand.